Registry tracking use of the CytoSorb blood-filter device in critically ill patients
Records real-world use of the CytoSorb device in critically ill people with serious conditions.
Plain-language title generated from the registry record
Registry title: CytOSorb TreatMent Of Critically Ill PatientS Registry
Key facts
- Where
- Roma and San Giovanni Rotondo, ItalySee the 2 sites
Where in Italy
- Ospedale Pediatrico Bambino GesùRoma, ItalyNo longer taking part
- IRCCS Ospedale Casa Sollievo della SofferenzaSan Giovanni Rotondo, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- CytoSorbents, Inc
- Trial code
- NCT05146336
- Record updated
- 20 October 2026
- Original description
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient careRead full original descriptionShow less
CytOSorb TreatMent Of Critically Ill PatientS Registry: International Registry on the Use of CytoSorb in the Critical Care Setting
Registry intended to provide a data repository and reporting infrastructure for the surveillance of CytoSorb device use in real-world critical care settings, and to serve as an objective, comprehensive, and scientifically-based resource to measure and improve the quality of patient care
Inclusion: Planned OR actual CytoSorb® 300 mL device utilization; Informed consent for prospective registry participation.
Exclusion: The occurrence of a complication or other medically justified circumstance that arises after written informed consent has been obtained from the patient and before or during the planned therapy and as a result of which the use of CytoSorb® 300 mL Adsorber is contraindicated or no longer appropriate; Intraoperative use of CytoSorb® 300 mL device during cardiac surgery only; Use of the CytoSorb® 300 mL device for antithrombotic removal only.